Patients who receive dual antiplatelet therapy (DAPT) after transcatheter aortic valve implantation (TAVI) have lower rates of stroke 1 year after the procedure, but similar rates of major ischemic and bleeding outcomes, compared with patients who do not receive DAPT, according to a recent study.